Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,982
archived clinical trials in
Endocrine

Use of NPSP558 in the Treatment of Hypoparathyroidism
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]) for the Treatment of Adults With Hypoparathyroidism
Status: Enrolling
Updated:  11/10/2015
Mayo Clinic Scottsdale
mi
from
Scottsdale, AZ
Use of NPSP558 in the Treatment of Hypoparathyroidism
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]) for the Treatment of Adults With Hypoparathyroidism
Status: Enrolling
Updated: 11/10/2015
Mayo Clinic Scottsdale
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Use of NPSP558 in the Treatment of Hypoparathyroidism
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]) for the Treatment of Adults With Hypoparathyroidism
Status: Enrolling
Updated:  11/10/2015
Advance Medical Research LLC
mi
from
Lakewood, CA
Use of NPSP558 in the Treatment of Hypoparathyroidism
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]) for the Treatment of Adults With Hypoparathyroidism
Status: Enrolling
Updated: 11/10/2015
Advance Medical Research LLC
mi
from
Lakewood, CA
Click here to add this to my saved trials
Use of NPSP558 in the Treatment of Hypoparathyroidism
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]) for the Treatment of Adults With Hypoparathyroidism
Status: Enrolling
Updated:  11/10/2015
Diabetes Associates
mi
from
Orange, CA
Use of NPSP558 in the Treatment of Hypoparathyroidism
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]) for the Treatment of Adults With Hypoparathyroidism
Status: Enrolling
Updated: 11/10/2015
Diabetes Associates
mi
from
Orange, CA
Click here to add this to my saved trials
Use of NPSP558 in the Treatment of Hypoparathyroidism
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]) for the Treatment of Adults With Hypoparathyroidism
Status: Enrolling
Updated:  11/10/2015
University of California-San Francisco VA Medical Center
mi
from
San Francisco, CA
Use of NPSP558 in the Treatment of Hypoparathyroidism
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]) for the Treatment of Adults With Hypoparathyroidism
Status: Enrolling
Updated: 11/10/2015
University of California-San Francisco VA Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Use of NPSP558 in the Treatment of Hypoparathyroidism
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]) for the Treatment of Adults With Hypoparathyroidism
Status: Enrolling
Updated:  11/10/2015
Palm Springs Research Institute
mi
from
Hialeah, FL
Use of NPSP558 in the Treatment of Hypoparathyroidism
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]) for the Treatment of Adults With Hypoparathyroidism
Status: Enrolling
Updated: 11/10/2015
Palm Springs Research Institute
mi
from
Hialeah, FL
Click here to add this to my saved trials
Use of NPSP558 in the Treatment of Hypoparathyroidism
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]) for the Treatment of Adults With Hypoparathyroidism
Status: Enrolling
Updated:  11/10/2015
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Use of NPSP558 in the Treatment of Hypoparathyroidism
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]) for the Treatment of Adults With Hypoparathyroidism
Status: Enrolling
Updated: 11/10/2015
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Use of NPSP558 in the Treatment of Hypoparathyroidism
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]) for the Treatment of Adults With Hypoparathyroidism
Status: Enrolling
Updated:  11/10/2015
University of Chicago Medical Center
mi
from
Chicago, IL
Use of NPSP558 in the Treatment of Hypoparathyroidism
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]) for the Treatment of Adults With Hypoparathyroidism
Status: Enrolling
Updated: 11/10/2015
University of Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Use of NPSP558 in the Treatment of Hypoparathyroidism
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]) for the Treatment of Adults With Hypoparathyroidism
Status: Enrolling
Updated:  11/10/2015
Indiana University School of Medicine
mi
from
Indianapolis, IN
Use of NPSP558 in the Treatment of Hypoparathyroidism
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]) for the Treatment of Adults With Hypoparathyroidism
Status: Enrolling
Updated: 11/10/2015
Indiana University School of Medicine
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Use of NPSP558 in the Treatment of Hypoparathyroidism
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]) for the Treatment of Adults With Hypoparathyroidism
Status: Enrolling
Updated:  11/10/2015
Massachusetts General Hospital
mi
from
Boston, MA
Use of NPSP558 in the Treatment of Hypoparathyroidism
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]) for the Treatment of Adults With Hypoparathyroidism
Status: Enrolling
Updated: 11/10/2015
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Use of NPSP558 in the Treatment of Hypoparathyroidism
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]) for the Treatment of Adults With Hypoparathyroidism
Status: Enrolling
Updated:  11/10/2015
Michigan Bone and Mineral Clinic, PC
mi
from
Detroit, MI
Use of NPSP558 in the Treatment of Hypoparathyroidism
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]) for the Treatment of Adults With Hypoparathyroidism
Status: Enrolling
Updated: 11/10/2015
Michigan Bone and Mineral Clinic, PC
mi
from
Detroit, MI
Click here to add this to my saved trials
Use of NPSP558 in the Treatment of Hypoparathyroidism
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]) for the Treatment of Adults With Hypoparathyroidism
Status: Enrolling
Updated:  11/10/2015
Mayo Clinic Rochester
mi
from
Rochester, MN
Use of NPSP558 in the Treatment of Hypoparathyroidism
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]) for the Treatment of Adults With Hypoparathyroidism
Status: Enrolling
Updated: 11/10/2015
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Use of NPSP558 in the Treatment of Hypoparathyroidism
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]) for the Treatment of Adults With Hypoparathyroidism
Status: Enrolling
Updated:  11/10/2015
Columbia University Medical Center
mi
from
New York, NY
Use of NPSP558 in the Treatment of Hypoparathyroidism
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]) for the Treatment of Adults With Hypoparathyroidism
Status: Enrolling
Updated: 11/10/2015
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Use of NPSP558 in the Treatment of Hypoparathyroidism
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]) for the Treatment of Adults With Hypoparathyroidism
Status: Enrolling
Updated:  11/10/2015
University Physicians Group
mi
from
Staten Island, NY
Use of NPSP558 in the Treatment of Hypoparathyroidism
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]) for the Treatment of Adults With Hypoparathyroidism
Status: Enrolling
Updated: 11/10/2015
University Physicians Group
mi
from
Staten Island, NY
Click here to add this to my saved trials
Use of NPSP558 in the Treatment of Hypoparathyroidism
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]) for the Treatment of Adults With Hypoparathyroidism
Status: Enrolling
Updated:  11/10/2015
Physician's East
mi
from
Greenville, NC
Use of NPSP558 in the Treatment of Hypoparathyroidism
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]) for the Treatment of Adults With Hypoparathyroidism
Status: Enrolling
Updated: 11/10/2015
Physician's East
mi
from
Greenville, NC
Click here to add this to my saved trials
Use of NPSP558 in the Treatment of Hypoparathyroidism
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]) for the Treatment of Adults With Hypoparathyroidism
Status: Enrolling
Updated:  11/10/2015
University of Cincinnati Bone Health and Osteoporosis Center
mi
from
Cincinnati, OH
Use of NPSP558 in the Treatment of Hypoparathyroidism
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]) for the Treatment of Adults With Hypoparathyroidism
Status: Enrolling
Updated: 11/10/2015
University of Cincinnati Bone Health and Osteoporosis Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Use of NPSP558 in the Treatment of Hypoparathyroidism
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]) for the Treatment of Adults With Hypoparathyroidism
Status: Enrolling
Updated:  11/10/2015
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Use of NPSP558 in the Treatment of Hypoparathyroidism
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]) for the Treatment of Adults With Hypoparathyroidism
Status: Enrolling
Updated: 11/10/2015
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Use of NPSP558 in the Treatment of Hypoparathyroidism
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]) for the Treatment of Adults With Hypoparathyroidism
Status: Enrolling
Updated:  11/10/2015
Cetero Research DGD Research Inc.
mi
from
San Antonio, TX
Use of NPSP558 in the Treatment of Hypoparathyroidism
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]) for the Treatment of Adults With Hypoparathyroidism
Status: Enrolling
Updated: 11/10/2015
Cetero Research DGD Research Inc.
mi
from
San Antonio, TX
Click here to add this to my saved trials
Use of NPSP558 in the Treatment of Hypoparathyroidism
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]) for the Treatment of Adults With Hypoparathyroidism
Status: Enrolling
Updated:  11/10/2015
Hillcrest Family Health Center
mi
from
Waco, TX
Use of NPSP558 in the Treatment of Hypoparathyroidism
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]) for the Treatment of Adults With Hypoparathyroidism
Status: Enrolling
Updated: 11/10/2015
Hillcrest Family Health Center
mi
from
Waco, TX
Click here to add this to my saved trials
Use of NPSP558 in the Treatment of Hypoparathyroidism
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]) for the Treatment of Adults With Hypoparathyroidism
Status: Enrolling
Updated:  11/10/2015
The Vancouver Clinic
mi
from
Vancouver, WA
Use of NPSP558 in the Treatment of Hypoparathyroidism
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]) for the Treatment of Adults With Hypoparathyroidism
Status: Enrolling
Updated: 11/10/2015
The Vancouver Clinic
mi
from
Vancouver, WA
Click here to add this to my saved trials
Use of NPSP558 in the Treatment of Hypoparathyroidism
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]) for the Treatment of Adults With Hypoparathyroidism
Status: Enrolling
Updated:  11/10/2015
Chetre Hospitalier Universitaire de Liege
mi
from
Liege,
Use of NPSP558 in the Treatment of Hypoparathyroidism
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]) for the Treatment of Adults With Hypoparathyroidism
Status: Enrolling
Updated: 11/10/2015
Chetre Hospitalier Universitaire de Liege
mi
from
Liege,
Click here to add this to my saved trials
Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
An 8-Week Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
Status: Enrolling
Updated:  11/11/2015
Baptist Health Center for Clinical Research
mi
from
Little Rock, AR
Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
An 8-Week Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
Status: Enrolling
Updated: 11/11/2015
Baptist Health Center for Clinical Research
mi
from
Little Rock, AR
Click here to add this to my saved trials
Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
An 8-Week Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
Status: Enrolling
Updated:  11/11/2015
Genesis Research
mi
from
San Diego, CA
Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
An 8-Week Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
Status: Enrolling
Updated: 11/11/2015
Genesis Research
mi
from
San Diego, CA
Click here to add this to my saved trials
Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
An 8-Week Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
Status: Enrolling
Updated:  11/11/2015
San Diego Clinical Trials
mi
from
San Diego, CA
Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
An 8-Week Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
Status: Enrolling
Updated: 11/11/2015
San Diego Clinical Trials
mi
from
San Diego, CA
Click here to add this to my saved trials
Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
An 8-Week Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
Status: Enrolling
Updated:  11/11/2015
Meridien Research
mi
from
Bradenton, FL
Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
An 8-Week Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
Status: Enrolling
Updated: 11/11/2015
Meridien Research
mi
from
Bradenton, FL
Click here to add this to my saved trials
Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
An 8-Week Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
Status: Enrolling
Updated:  11/11/2015
Clinical Research of South Florida
mi
from
Coral Gables, FL
Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
An 8-Week Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
Status: Enrolling
Updated: 11/11/2015
Clinical Research of South Florida
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
An 8-Week Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
Status: Enrolling
Updated:  11/11/2015
Well Pharma Medical Research
mi
from
Miami, FL
Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
An 8-Week Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
Status: Enrolling
Updated: 11/11/2015
Well Pharma Medical Research
mi
from
Miami, FL
Click here to add this to my saved trials
Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
An 8-Week Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
Status: Enrolling
Updated:  11/11/2015
Regional Urology
mi
from
Shreveport, LA
Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
An 8-Week Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
Status: Enrolling
Updated: 11/11/2015
Regional Urology
mi
from
Shreveport, LA
Click here to add this to my saved trials
Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
An 8-Week Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
Status: Enrolling
Updated:  11/11/2015
Premier Urology Associates, LLC, dba AdvanceMed Research
mi
from
Lawrence Township, NJ
Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
An 8-Week Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
Status: Enrolling
Updated: 11/11/2015
Premier Urology Associates, LLC, dba AdvanceMed Research
mi
from
Lawrence Township, NJ
Click here to add this to my saved trials
Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
An 8-Week Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
Status: Enrolling
Updated:  11/11/2015
The Urological Institute of Northeastern New York
mi
from
Albany, NY
Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
An 8-Week Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
Status: Enrolling
Updated: 11/11/2015
The Urological Institute of Northeastern New York
mi
from
Albany, NY
Click here to add this to my saved trials
Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
An 8-Week Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
Status: Enrolling
Updated:  11/11/2015
Accumed Research Associates
mi
from
Garden City, NY
Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
An 8-Week Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
Status: Enrolling
Updated: 11/11/2015
Accumed Research Associates
mi
from
Garden City, NY
Click here to add this to my saved trials
Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
An 8-Week Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
Status: Enrolling
Updated:  11/11/2015
Bruce R. GIlbert, MD, PhD, PC
mi
from
Great Neck, NY
Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
An 8-Week Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
Status: Enrolling
Updated: 11/11/2015
Bruce R. GIlbert, MD, PhD, PC
mi
from
Great Neck, NY
Click here to add this to my saved trials
Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
An 8-Week Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
Status: Enrolling
Updated:  11/11/2015
Manhattan Medical Research Practice PLLC
mi
from
New York, NY
Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
An 8-Week Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
Status: Enrolling
Updated: 11/11/2015
Manhattan Medical Research Practice PLLC
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
An 8-Week Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
Status: Enrolling
Updated:  11/11/2015
Volunteer Research
mi
from
Knoxville, TN
Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
An 8-Week Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
Status: Enrolling
Updated: 11/11/2015
Volunteer Research
mi
from
Knoxville, TN
Click here to add this to my saved trials
Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
An 8-Week Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
Status: Enrolling
Updated:  11/11/2015
Clinical Research Associates
mi
from
Nashville, TN
Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
An 8-Week Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
Status: Enrolling
Updated: 11/11/2015
Clinical Research Associates
mi
from
Nashville, TN
Click here to add this to my saved trials
Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
An 8-Week Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
Status: Enrolling
Updated:  11/11/2015
Physicians Research Options
mi
from
Draper, UT
Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
An 8-Week Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
Status: Enrolling
Updated: 11/11/2015
Physicians Research Options
mi
from
Draper, UT
Click here to add this to my saved trials
Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
An 8-Week Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
Status: Enrolling
Updated:  11/11/2015
Clinical Research Associates of Tidewater
mi
from
Norfolk, VA
Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
An 8-Week Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
Status: Enrolling
Updated: 11/11/2015
Clinical Research Associates of Tidewater
mi
from
Norfolk, VA
Click here to add this to my saved trials
Treatment of Hyperandrogenism Versus Insulin Resistance in Infertile Polycystic Ovary Syndrome (PCOS) Women
Treatment of Hyperandrogenism vs. Insulin Resistance in Infertile PCOS Women
Status: Enrolling
Updated:  11/13/2015
University of Pennsylvania, Department of Obstetrics and Gynecology
mi
from
Philadelphia, PA
Treatment of Hyperandrogenism Versus Insulin Resistance in Infertile Polycystic Ovary Syndrome (PCOS) Women
Treatment of Hyperandrogenism vs. Insulin Resistance in Infertile PCOS Women
Status: Enrolling
Updated: 11/13/2015
University of Pennsylvania, Department of Obstetrics and Gynecology
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Treatment of Hyperandrogenism Versus Insulin Resistance in Infertile Polycystic Ovary Syndrome (PCOS) Women
Treatment of Hyperandrogenism vs. Insulin Resistance in Infertile PCOS Women
Status: Enrolling
Updated:  11/13/2015
Penn State College of Medicine, Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Treatment of Hyperandrogenism Versus Insulin Resistance in Infertile Polycystic Ovary Syndrome (PCOS) Women
Treatment of Hyperandrogenism vs. Insulin Resistance in Infertile PCOS Women
Status: Enrolling
Updated: 11/13/2015
Penn State College of Medicine, Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Safety and Efficacy of CTAP101 Capsules for Treatment of SHPT and Vitamin D Insufficiency
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of CTAP101 Capsules to Treat Secondary Hyperparathyroidism in Subjects With Stage 3 or 4 Chronic Kidney Disease and Vitamin D Insufficiency
Status: Enrolling
Updated:  11/13/2015
OPKO Renal
mi
from
Bannockburn, IL
Safety and Efficacy of CTAP101 Capsules for Treatment of SHPT and Vitamin D Insufficiency
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of CTAP101 Capsules to Treat Secondary Hyperparathyroidism in Subjects With Stage 3 or 4 Chronic Kidney Disease and Vitamin D Insufficiency
Status: Enrolling
Updated: 11/13/2015
OPKO Renal
mi
from
Bannockburn, IL
Click here to add this to my saved trials
Post-Gastric Bypass Hypoglycemia
Prevention of Hypoglycemia in Patients With Post-Gastric Bypass Hyperinsulinemic Hypoglycemia
Status: Enrolling
Updated:  11/16/2015
Univ of Minnesota
mi
from
Minneapolis, MN
Post-Gastric Bypass Hypoglycemia
Prevention of Hypoglycemia in Patients With Post-Gastric Bypass Hyperinsulinemic Hypoglycemia
Status: Enrolling
Updated: 11/16/2015
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Post-Gastric Bypass Hypoglycemia
Prevention of Hypoglycemia in Patients With Post-Gastric Bypass Hyperinsulinemic Hypoglycemia
Status: Enrolling
Updated:  11/16/2015
Univ of Minnesota
mi
from
Minneapolis, MN
Post-Gastric Bypass Hypoglycemia
Prevention of Hypoglycemia in Patients With Post-Gastric Bypass Hyperinsulinemic Hypoglycemia
Status: Enrolling
Updated: 11/16/2015
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
mi
from
Mission Viejo, CA
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
mi
from
Mission Viejo, CA
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
mi
from
Newport Beach, CA
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
mi
from
Newport Beach, CA
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
mi
from
Bridgeport, CT
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
mi
from
Bridgeport, CT
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
mi
from
Melbourne, FL
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
mi
from
Melbourne, FL
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
mi
from
Winter Park, FL
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
mi
from
Winter Park, FL
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
mi
from
Chicago, IL
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
mi
from
Kansas City, KA
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
mi
from
Kansas City, KA
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
mi
from
Biddeford, ME
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
mi
from
Biddeford, ME
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
mi
from
Boston, MA
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials